A Single Dose Bioavailability Study of 2 New Tablet Formulations of Neratinib Compared With a Reference Capsule in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 11 May 2012
At a glance
- Drugs Neratinib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Wyeth
- 11 May 2012 Actual initiation date changed from Feb 2009 to Jan 2009 as reported by ClinicalTrials.gov.
- 11 May 2012 Additional company (Puma Biotechnology) added in association as reported by ClinicalTrials.gov.
- 28 Apr 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.